Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985852 · ClinicalTrials.gov registry record · NA
Broadening the Reach, Impact, and Delivery of Genetic Services
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 3,073
- Enrollment target
NCT03985852: Completed NA study, sponsored by University of Utah.
NCT03985852 is a NA study that has completed, run by University of Utah. The registered enrollment target is 3,073 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (119% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03985852, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,073 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the uptake of genetic testing among patients randomized with two different models of genetic services delivery (a patient-directed model and an enhanced standard of care model) and examine whether the impact on uptake differs by race/ethnicity and rurality. This study will also compare the effect of these delivery models on adherence to cancer prevention and screening recommendations and other patient responses.
Primary Outcome
Percentage of patients who decide to receive genetic testing
Interventions
- OTHER Patient Directed Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,073 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT03985852 record still lists
NCT03985852 is an interventional study that assigns participants to a tested intervention. Its 3,073 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (119% higher).
The record links to 0 conditions, and to 1 intervention - of which Patient Directed Standard of Care is the first listed.
NCT03985852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03985852 about?
NCT03985852 is a clinical study titled "Broadening the Reach, Impact, and Delivery of Genetic Services". The purpose of this study is to compare the uptake of genetic testing among patients randomized with two different models of genetic services delivery (a patient-directed model and an enhanced standard of care model) and examine whether the impact on uptake differs by race/ethnicity and rurality. Th...
What is the current status of trial NCT03985852?
This trial is currently completed. It is a NA study. The enrollment target is 3,073 participants. The study started on 2020-02-19. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT03985852?
The interventions under investigation include: Patient Directed Standard of Care (OTHER).
Who is sponsoring clinical trial NCT03985852?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03985852's enrollment target sits among peer trials
3,073 40th of 2000 higher than 1,961 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI